From: A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort
Sampling
Banking constitutional DNA
Banking plasma
Banking serum
NPM-ALKb (ALK+ ALCL)c
Anti-ALK Abd (ALK+ ALCL)
Baselinea
x
Day 1 Cycle 3
End of first-line treatment
First relapse